MRK
Merck & Company Inc.
NYSE:MRK
$287.7B MC · 2.5B shares · 75.0K employees

Merck & Company Inc. Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Content on this page require a membership to view — $9/mo.

News

This data requires membership
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
biotech.bet © 2026